Body Dysmorphic Disorders: Clinical Trials

5 trials for Body Dysmorphic Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown, 1 withdrawn. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Recruiting 1, Unknown 1, Withdrawn 1

Follow Body Dysmorphic Disorders: new trials by email Literature Review of Body Dysmorphic Disorders trials Research Report on Body Dysmorphic Disorders

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Dextromethorphan in OCD and Related Disorders
Fluoxetine, Dextromethorphan - Obsessive-Compulsive Disorder, Illness Anxiety Disorder
Phase 2RecruitingStanford University602022-01-202026-05-20
Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder
Psilocybin - Body Dysmorphic Disorders
Phase 2CompletedNew York State Psychiatric Institute122021-02-262023-03-13
Milk Thistle in Body Dysmorphic Disorder
Milk Thistle, Placebo - Body Dysmorphic Disorder
Phase 2WithdrawnUniversity of Chicago2016-10-012022-12-28
Oxytocin Administration in BDD and OCD
Oxytocin, Placebo - Body Dysmorphic Disorder, Obsessive-compulsive Disorder
Phase 2CompletedMassachusetts General Hospital412014-12-012018-11-23
Study of Patients With Body Image Issues Treated With 2 Different Behavioral Interventions
Crooked Mirror Externalization Therapy, Mirror Retraining Method - Body Dysmorphic Disorders
Phase 2UnknownWestwood Institute for Anxiety Disorders, Inc202007-04-012011-03-16

Narrower conditions

Obsessive-Compulsive Disorder (3)

Broader conditions

Mental Disorders (5)  ·  Somatoform Disorders (5)  ·  Anxiety Disorders (3)

Interventions

Dextromethorphan (1)  ·  Fluoxetine (1)  ·  Oxytocin (1)  ·  Psilocybin (1)  ·  Silymarin (1)  ·  Sugars (1)  ·  milk-thistle extract (1)

Sponsors

Massachusetts General Hospital (1)  ·  New York State Psychiatric Institute (1)  ·  Stanford University (1)  ·  University of Chicago (1)  ·  Westwood Institute for Anxiety Disorders, Inc (1)

Countries

United States (5)

Top investigators

Angela Fang, Ph.D. (1)  ·  Eda Gorbis, PhD, LMFT (1)  ·  Franklin Schneier, MD (1)  ·  Jon E Grant, JD, MD, MPH (1)  ·  Peter J van Roessel, MD PhD (1)

Results publications

PMID 40458078